Albireo Pharma Inc ROIC
What is the ROIC of Albireo Pharma Inc?
The ROIC of Albireo Pharma Inc is -6.84%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Albireo Pharma Inc
What does Albireo Pharma Inc do?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Companies with roic similar to Albireo Pharma Inc
- Conduent Inc has ROIC of -6.86%
- Conduent Inc has ROIC of -6.86%
- China Green Agriculture Inc has ROIC of -6.85%
- Nitco has ROIC of -6.85%
- Colipays, S.A has ROIC of -6.85%
- Vobile has ROIC of -6.84%
- Albireo Pharma Inc has ROIC of -6.84%
- Invesco Asia Trust Plc has ROIC of -6.84%
- Just Eat Takeaway.com N.V has ROIC of -6.84%
- Cairn Plc has ROIC of -6.84%
- CommScope Inc has ROIC of -6.83%
- Guidewire Software has ROIC of -6.83%
- Union Metallurgique de la Haute-Seine S.A has ROIC of -6.82%